Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus
Milne, A.; Hopkirk, N.; Lucas, C.R.; Waldon, J.; Foo, Y.
New Zealand Medical Journal 107(980): 243
1994
ISSN/ISBN: 0028-8446 PMID: 8208497 Document Number: 424899
Document emailed within 1 workday
Related Documents
Blumberg, B.S.; Millman, I.; Venkateswaran, P.S.; Thyagarajan, S.P. 1989: Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus Cancer Detection and Prevention 14(2): 195-201Xin-Hua, W.; Chang-Qing, L.; Xing-Bo, G.; Lin-Chun, F. 2001: A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B Southeast Asian Journal of Tropical Medicine and Public Health 32(1): 140-142
Srividya, N.; Periwal, S. 1995: Diuretic, hypotensive and hypoglycaemic effect of Phyllanthus amarus Indian Journal of Experimental Biology 33(11): 861-864
Thomas, H.C. 1989: Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers: implications for the treatment of chronic HBV carriers Quarterly Journal of Medicine 73(270): 873-874
Bartolomé, J.; Castillo, I.; Mora, I.; Gutiez, J.; Porres, J.C.; Carreño, V. 1988: Different levels of hepatitis B virus replication among hepatitis be antigen-positive chronic carriers Acta Virologica 32(3): 193-197
Sampliner, R. 1977: Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. the need for liver biopsy JAMA 237(1): 50-51
Altindag, A.; Cadirci, D.; Sirmatel, F. 2009: Depression and health related quality of life in non-cirrhotic chronic hepatitis B patients and hepatitis B carriers Neurosciences 14(1): 56-59
Van der Ploeg, C.P.B.; Kateman, H.; Vermeer-de Bondt, P.E.; Verkerk, P.H. 2004: Increased risk of hepatitis B due to incomplete or untimely immunisation in one-quarter of infants of hepatitis-B-virus carriers Nederlands Tijdschrift Voor Geneeskunde 148(37): 1820-1824
Sansonno, D.E.; Bufano, G.; Fiore, G.; Manghisi, O.G. 1987: Correlation between hepatitis B core antigen in liver tissue and hepatitis B virus DNA in the serum of HBV-infection chronic carriers Archives of Pathology and Laboratory Medicine 111(8): 689-690
Zhu, L.G.; Jiang, J.; Song, C.; Zou, Y.; Xu, J.F.; Liu, H.J.; Peng, H.; Hu, Z.B.; Zhu, F.C.; Shen, H.B.; Zhai, X.J. 2016: A cohort study of hepatitis B virus carriers progressing to chronic hepatitis in Jiangsu province, 2012-2014 Zhonghua Liu Xing Bing Xue Za Zhi 37(11): 1463-1467
Wilkinson, B.V. 1979: Legal implications of failure to respond and/or transport Emergency Medical Services 8(5): 96 98
Lee, Y.H.; Bae, S.-C.; Song, G.G. 2013: Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy Clinical and Experimental Rheumatology 31(1): 118-121
Wunderink, R.G. 1995: Ventilator-associated pneumonia. Failure to respond to antibiotic therapy Clinics in Chest Medicine 16(1): 173-193
Pongpipat, D.; Suvatte, V.; Assateerawatts, A. 1986: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg Asian Pacific Journal of Allergy and Immunology 4(1): 33-36
Phair, J.; Kauffman, C.A.; Bjornson, A.; Adams, L.; Linnemann, C. 1978: Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function Journal of Laboratory and Clinical Medicine 92(5): 822-828
Jowitt, D. 2011: Contribution of hepatitis B vaccination programmes initiated by Alexander Milne and Dr Christopher Moyes to the decline in prevalence of hepatitis B infection in pregnant women in the Midlands region of the North Is, New Zealand New Zealand Medical Journal 124(1334): 123-124
Van Etta, L.L.; Peterson, L.R.; Gerding, D.N. 1981: Asymptomatic hepatitis B carriers in a family New England Journal of Medicine 305(18): 1093-1094
Okuda, K. 1994: Counselling for hepatitis B virus carriers Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 15(1): 3-6
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Kaboth, U.; Klinge, O.; Schober, A.; Winckler, K.; Creutzfeldt, W. 1976: Serial biopsies in healthy carriers of hepatitis Bs antigen Deutsche Medizinische Wochenschrift 101(34): 1259-1260